Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:13:04.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 is shown, and an outdated government funding operating-status notice has been removed.
    Difference
    0.4%
    Check dated 2026-02-11T10:16:32.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a banner notice about a lapse in government funding and the NIH Clinical Center's status with links for updates. The page revision label was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:33:45.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page adds a glossary toggle, a 'Last Update Submitted that Met QC Criteria' indicator, 'No FEAR Act Data' and 'Revision: v3.4.0', while removing the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' elements.
    Difference
    0.2%
    Check dated 2026-01-28T04:11:14.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Minor revision history updates show Revision: v3.3.4 added and Revision: v3.3.3 removed, which do not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T00:52:15.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A centralized Locations section now lists all study sites by state (Arizona, California, Florida, Indiana, Kentucky, Missouri, New York, Ohio, Oregon, Pennsylvania, Rhode Island, Virginia), replacing the previous per-state location headers. The page also shows an updated Revision: v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:20:11.000Z thumbnail image

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.